Current stock page

Financial Data

SNY Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareDrug Manufacturers - GeneralScore data as of Nov 13, 2026

SNYSanofi

Healthcare / Drug Manufacturers - General

Leader

Strong Relative Position

BullishEdge 8/10
$48.37−$0.09 (−0.19%)

Latest quote

  • Momentum
    64
  • Value
    77
  • Quality
    57
  • Risk resilience
    85
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
0
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated —.

Income statement
0 periods

No quarterly history is available for this statement.

Cash flow statement
0 periods

No quarterly history is available for this statement.

Balance sheet
0 periods

No quarterly history is available for this statement.

Key financial metrics
0 periods

No quarterly history is available for this statement.

Financial ratios
0 periods

No quarterly history is available for this statement.

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe25.1x
Pb1.44x
Gross Margin73.44%
Operating Margin21.55%
ROE5.84%
ROIC7.49%
Debt To Equity0.27
FCF Yield14.41%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$48.37
Volume1.68M
RSI (14)76.2
MACD1.89
MACD signal1.46
MACD histogram0.43
ADX (14)38.95
SMA (50)$42.68
SMA (200)$44.36
ATR (14)$0.97
Historical volatility (annualized)30.43%
Volume (20-day average)4.51M

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score85/100
Beta0.29
Annual volatility24.14%
Max Drawdown-25.26%
Sharpe Ratio-0.37
VaR (95%, 1-day)-2.31%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

SNY Financial Data FAQ

What is Sanofi's revenue?

Sanofi's revenue is one of the core financial data points for SNY. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Sanofi's revenue growing?

Revenue growth shows whether Sanofi is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is SNY's EPS?

SNY's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Sanofi's net income?

Sanofi's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Sanofi generate?

Free cash flow shows how much cash Sanofi generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Sanofi have?

Cash and debt help frame SNY's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.